H-Cyte-Logo-Final-CMYK (1).jpg
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
18. November 2019 08:00 ET | H-CYTE, Inc.
TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
Atta Behfar, M.D., Ph.D.
H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors
30. Juli 2019 08:00 ET | H-CYTE, Inc.
TAMPA, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung...
Andre Terzic, MD, PhD
H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors
29. Juli 2019 08:00 ET | H-CYTE, Inc.
TAMPA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung...
H-Cyte-Logo-Final-CMYK (1).jpg
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol
12. Juli 2019 08:30 ET | Medovex Corp.
TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness of a change in the company’s name from “Medovex Corp.” to...
H-Cyte-Logo-Final-CMYK (1).jpg
Medovex Corporation Updates Name Change and Full Rebranding to H-CYTE
01. Juli 2019 08:00 ET | Medovex Corp.
TAMPA, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today updated investors on its name change and rebranding to H-CYTE. The announcement underscores the Company's broader...